Radiation pneumonitis after definitive chemoradiation and durvalumab for non-small cell lung cancer

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)249-251
Number of pages3
JournalLung Cancer
Volume150
DOIs
StatePublished - Dec 2020

Keywords

  • Chemoradiation
  • Immune-Checkpoint inhibitor
  • Lung cancer
  • Pneumonitis

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this